Kogieleum Naidoo

18PUBLICATIONS
53CO-AUTHORS
Social epidemiologyEpidemiological modellingMedical bacteriologyGene and molecular therapyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 17, 2026
A Retrospective Analysis Examining the Impact of Educational Attainment and Social Determinants of Health on Rifampicin-Resistant Tuberculosis Treatment Outcomes.

|Feb 18, 2026
Risk Factors for Immunological Sensitization to Mycobacterium tuberculosis and Progression to Incident TB Disease Among HIV-uninfected Adults in a High Burden Setting.

Humphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland

|Feb 09, 2026
Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles From Asymptomatic Tuberculosis Patients.

Luisa Maria Nieto Ramirez, Kimberly Shelton, John T Belisle

|Dec 30, 2025
Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Emmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo

|Oct 08, 2025
Perinatal transmission and cure of extensively drug-resistant tuberculosis in an infant.

V Singh, R Perumal, M Wessels

|Jun 24, 2025
Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.

Sara Keller, Kogieleum Naidoo, Medhane Zekarias

Pageof 3

Frequent Collaborators

5 joint publications

Rubeshan Perumal

2 joint publications

Thomas Scriba

2 joint publications

Keeren Lutchminarain

2 joint publications

Humphrey Mulenga